Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 6Neuroblastoma 5Central Nervous System Neoplasms 5Gliosarcoma 4Medulloblastoma 3Glioma 3Brain Neoplasms 3Sarcoma 2Rhabdoid Tumor 2Recurrence 2Pinealoma 2Ependymoma 2Sarcoma, Ewing 1Rhabdomyosarcoma 1Pyloric Stenosis, Hypertrophic 1Osteosarcoma 1Oligodendroglioma 1Neurofibromatosis 1 1Neurofibroma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Lymphoma 1Leukemia 1Histiocytosis, Langerhans-Cell 1Carcinoma 1Brainstem Glioma 1Astrocytoma 1

Interventions

Thalidomide 1Etoposide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brainstem Glioma × Celecoxib × CNS × Clear all
NCT01756989 2014-05-08

ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors

Helsinki University Central Hospital

Phase 2 Completed
50 enrolled
CNS

Brainstem Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡